Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2017 Filed Feb 28, 2017 17:01 UTC |
Fincher Ronald MorganChief Operating Officer
|
Tax withholdingCommon Stock | 362 | $44.94 | $16,268.28 |
DisclosureSEC source: 0000899243-17-005582 · doc4.xml · nonDerivative · entry 2 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,034 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 17:00 UTC |
JACOBS JOEY ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,374 | $44.94 | $61,747.56 |
DisclosureSEC source: 0000899243-17-005579 · doc4.xml · nonDerivative · entry 2 JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,221 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 17:00 UTC |
TURNER BRENTPresident
|
Tax withholdingCommon Stock | 353 | $44.94 | $15,863.82 |
DisclosureSEC source: 0000899243-17-005580 · doc4.xml · nonDerivative · entry 2 TURNER BRENT · CIK 0001243882 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,324 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 17:02 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 318 | $44.94 | $14,290.92 |
DisclosureSEC source: 0000899243-17-005583 · doc4.xml · nonDerivative · entry 2 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,821 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 22:03 UTC |
Schwieger ScottChief Compliance Officer
|
Tax withholdingCommon Stock | 195 | $44.94 | $8,763.30 |
DisclosureSEC source: 0000899243-17-005584 · doc4.xml · nonDerivative · entry 2 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,812 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 22:00 UTC |
GOLDBERG RANDALL PVP of Business Development
|
Tax withholdingCommon Stock | 234 | $44.94 | $10,515.96 |
DisclosureSEC source: 0000899243-17-005578 · doc4.xml · nonDerivative · entry 2 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,290 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 22:00 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 195 | $44.94 | $8,763.30 |
DisclosureSEC source: 0000899243-17-005576 · doc4.xml · nonDerivative · entry 2 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,017 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:01 UTC |
Fincher Ronald MorganChief Operating Officer
|
Tax withholdingCommon Stock | 281 | $43.24 | $12,150.44 |
DisclosureSEC source: 0000899243-17-005582 · doc4.xml · nonDerivative · entry 1 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,396 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:00 UTC |
JACOBS JOEY ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,413 | $43.24 | $61,098.12 |
DisclosureSEC source: 0000899243-17-005579 · doc4.xml · nonDerivative · entry 1 JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,595 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:00 UTC |
TURNER BRENTPresident
|
Tax withholdingCommon Stock | 258 | $43.24 | $11,155.92 |
DisclosureSEC source: 0000899243-17-005580 · doc4.xml · nonDerivative · entry 1 TURNER BRENT · CIK 0001243882 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,677 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:02 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 234 | $43.24 | $10,118.16 |
DisclosureSEC source: 0000899243-17-005583 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,139 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:03 UTC |
Schwieger ScottChief Compliance Officer
|
Tax withholdingCommon Stock | 212 | $43.24 | $9,166.88 |
DisclosureSEC source: 0000899243-17-005584 · doc4.xml · nonDerivative · entry 1 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,007 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:00 UTC |
GOLDBERG RANDALL PVP of Business Development
|
Tax withholdingCommon Stock | 254 | $43.24 | $10,982.96 |
DisclosureSEC source: 0000899243-17-005578 · doc4.xml · nonDerivative · entry 1 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,524 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:00 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 160 | $43.24 | $6,918.40 |
DisclosureSEC source: 0000899243-17-005576 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,212 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 18:03 UTC |
Fincher Ronald MorganChief Operating Officer
|
Tax withholdingCommon Stock | 499 | $38.80 | $19,361.20 |
DisclosureSEC source: 0000899243-17-002959 · doc4.xml · nonDerivative · entry 1 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,677 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 18:03 UTC |
JACOBS JOEY ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,923 | $38.80 | $74,612.40 |
DisclosureSEC source: 0000899243-17-002958 · doc4.xml · nonDerivative · entry 1 JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,008 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 18:02 UTC |
TURNER BRENTPresident
|
Tax withholdingCommon Stock | 461 | $38.80 | $17,886.80 |
DisclosureSEC source: 0000899243-17-002955 · doc4.xml · nonDerivative · entry 1 TURNER BRENT · CIK 0001243882 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,935 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 18:02 UTC |
Howard Christopher LEVP, GC and Secretary
|
Tax withholdingCommon Stock | 405 | $38.80 | $15,714.00 |
DisclosureSEC source: 0000899243-17-002956 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,373 Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 01:08 UTC |
Schwieger ScottChief Compliance Officer
|
Tax withholdingCommon Stock | 81 | $38.80 | $3,142.80 |
DisclosureSEC source: 0000899243-17-002991 · doc4.xml · nonDerivative · entry 6 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,219 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 23:04 UTC |
GOLDBERG RANDALL PVP of Business Development
|
Tax withholdingCommon Stock | 98 | $38.80 | $3,802.40 |
DisclosureSEC source: 0000899243-17-002960 · doc4.xml · nonDerivative · entry 1 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,778 Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 23:02 UTC |
Duckworth David M.Chief Financial Officer
|
Tax withholdingCommon Stock | 316 | $38.80 | $12,260.80 |
DisclosureSEC source: 0000899243-17-002957 · doc4.xml · nonDerivative · entry 1 Duckworth David M. · CIK 0001555047 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,372 Read SEC document |
| January 03, 2017 Filed Jan 27, 2017 22:01 UTC |
GRIECO WILLIAMDirector
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.72 | $0.00 |
DisclosureSEC source: 0000899243-17-002109 · doc4.xml · derivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 27, 2017 22:01 UTC |
GRIECO WILLIAMDirector
|
Exercise / conversionCommon Stock | 5,000 | $12.72 | $63,600.00 |
DisclosureSEC source: 0000899243-17-002109 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:10 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 14,000 | $35.14 | $491,960.00 |
DisclosureSEC source: 0000899243-16-035846 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,267,951 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.69 to $35.61, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · balance_after: The shares are owned of record as follows: (i) 1,141,420 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 2,086,697 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 606,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 318,466 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (vi) 326,164 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (vii) 167,388 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (viii) 454,671 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (ix) 1,036,001 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (x) 183,205 shares by Waud Capital Partners III, L.P. ("WCP III"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F5 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 15, 2016 Filed Dec 17, 2016 01:10 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 8,913 | $34.23 | $305,091.99 |
DisclosureSEC source: 0000899243-16-035846 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,281,951 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.01 to $34.44, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 15, 2016 Filed Dec 17, 2016 01:10 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 5,087 | $33.67 | $171,279.29 |
DisclosureSEC source: 0000899243-16-035846 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,290,864 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $33.01 to $34.00, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price. F5 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 00:55 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 700 | $33.88 | $23,716.00 |
DisclosureSEC source: 0000899243-16-035571 · doc4.xml · nonDerivative · entry 5 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,295,951 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $33.68 to $34.36, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia F8 · balance_after: The shares are owned of record as follows: (i) 1,141,420 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 2,086,697 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 634,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 318,466 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (vi) 326,164 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (vii) 167,388 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (viii) 454,671 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (ix) 1,036,001 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (x) 183,205 shares by Waud Capital Partners III, L.P. ("WCP III"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F7 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F9 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 00:55 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 13,300 | $33.20 | $441,560.00 |
DisclosureSEC source: 0000899243-16-035571 · doc4.xml · nonDerivative · entry 4 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,296,651 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $32.68 to $33.67, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F9 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 00:55 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 5,159 | $35.51 | $183,196.09 |
DisclosureSEC source: 0000899243-16-035571 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,309,951 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $35.31 to $35.97, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F9 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 00:55 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 8,841 | $34.86 | $308,197.26 |
DisclosureSEC source: 0000899243-16-035571 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,315,110 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.31 to $35.305, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F9 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| December 12, 2016 Filed Dec 15, 2016 00:55 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 14,000 | $35.79 | $501,060.00 |
DisclosureSEC source: 0000899243-16-035571 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,323,951 F1 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $35.69 to $36.01, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price. F7 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F9 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 19:23 UTC |
WAUD CAPITAL PARTNERS III, L.L.C.10% owner
WAUD CAPITAL PARTNERS III, L.P.10% owner
WAUD CAPITAL PARTNERS QP III, L.P.10% owner
WCP FIF III (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES III, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 287,668 | $47.74 | $13,733,270.32 |
DisclosureSEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 3 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,841,265 F6 · shares: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III. F7 · balance_after: The reported shares are owned of record as follows: (i) 183,205 shares by WCP III, (ii) 1,036,001 shares by Waud QP III, (iii) 454,671 shares by WCP FIF III and (iv) 167,388 shares by Waud Affiliates III. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 75,000 | $50.76 | $3,807,000.00 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 7 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,337,951 F9 · shares: Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust"). F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.70 to $51.12, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (9) to this Form 4. F14 · balance_after: The shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by WCP QP II, (iii) 676,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 318,466 shares by WCP FIF II, (vi) 326,164 shares by Waud Affiliates II, (vii) 167,388 shares by Waud Affiliates III, (viii) 454,671 shares by WCP FIF III, (ix) 1,036,001 shares by WCP QP III, (x) 183,205 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F13 · ownership.nature: Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 287,668 | $47.74 | $13,733,270.32 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 6 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,412,951 F8 · shares: Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 521,033 | $47.74 | $24,874,115.42 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 5 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,700,619 F7 · shares: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2016 Filed Sep 16, 2016 19:27 UTC |
WAUD CAPITAL PARTNERS II, L.L.C.10% owner
WAUD CAPITAL PARTNERS II, L.P.10% owner
WAUD CAPITAL PARTNERS QP II, L.P.10% owner
WCP FIF II (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES II, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 521,033 | $47.74 | $24,874,115.42 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 3 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,872,747 F6 · shares: Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II. F7 · balance_after: The reported shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by Waud QP II, (iii) 318,466 shares by WCP FIF II and (iv) 326,164 shares by Waud Affiliates II. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:23 UTC |
WAUD CAPITAL PARTNERS III, L.L.C.10% owner
WAUD CAPITAL PARTNERS III, L.P.10% owner
WAUD CAPITAL PARTNERS QP III, L.P.10% owner
WCP FIF III (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES III, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 123,473 | $49.24 | $6,079,810.52 |
DisclosureSEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,128,933 F4 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 123,473 | $49.24 | $6,079,810.52 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 4 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,221,652 F6 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 223,640 | $49.24 | $11,012,033.60 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,345,125 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:27 UTC |
WAUD CAPITAL PARTNERS II, L.L.C.10% owner
WAUD CAPITAL PARTNERS II, L.P.10% owner
WAUD CAPITAL PARTNERS QP II, L.P.10% owner
WCP FIF II (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES II, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 223,640 | $49.24 | $11,012,033.60 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,393,780 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:23 UTC |
WAUD CAPITAL PARTNERS III, L.L.C.10% owner
WAUD CAPITAL PARTNERS III, L.P.10% owner
WAUD CAPITAL PARTNERS QP III, L.P.10% owner
WCP FIF III (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES III, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 46,302 | $50.19 | $2,323,897.38 |
DisclosureSEC source: 0000899243-16-029177 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,252,406 F1 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 46,302 | $50.19 | $2,323,897.38 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,568,765 F3 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F12 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 23:25 UTC |
WAUD REEVE BDirector
|
SaleCommon stock, par value $0.01 per share | 83,861 | $50.19 | $4,208,983.59 |
DisclosureSEC source: 0000899243-16-029178 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,615,067 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F11 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F15 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F16 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:27 UTC |
WAUD CAPITAL PARTNERS II, L.L.C.10% owner
WAUD CAPITAL PARTNERS II, L.P.10% owner
WAUD CAPITAL PARTNERS QP II, L.P.10% owner
WCP FIF II (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES II, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 83,861 | $50.19 | $4,208,983.59 |
DisclosureSEC source: 0000899243-16-029179 · doc4.xml · nonDerivative · entry 1 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,617,420 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (1) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F8 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 01:03 UTC |
WAUD REEVE BDirector · 10% owner
|
SaleCommon stock, par value $0.01 per share | 3,275 | $51.23 | $167,778.25 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 4 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,698,928 F6 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 82 shares by WCP III, (ii) 1,800 shares by Waud QP III, (iii) 1,019 shares by WCP FIF III and (iv) 374 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F9 · balance_after: The shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by WCP QP II, (iii) 751,113 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (iv) 83,530 shares by Waud Family Partners, L.P. ("WFP LP"), (v) 418,098 shares by WCP FIF II, (vi) 428,204 shares by Waud Affiliates II, (vii) 219,756 shares by Waud Affiliates III, (viii) 596,913 shares by WCP FIF III, (ix) 1,287,433 shares by WCP QP III, (x) 194,606 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (xii) 795,667 shares by Crystal Cove LP. F8 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 01:03 UTC |
WAUD REEVE BDirector · 10% owner
|
SaleCommon stock, par value $0.01 per share | 5,933 | $51.23 | $303,947.59 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,702,203 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 21:05 UTC |
WAUD CAPITAL PARTNERS III, L.L.C.10% owner
WAUD CAPITAL PARTNERS III, L.P.10% owner
WAUD CAPITAL PARTNERS QP III, L.P.10% owner
WCP FIF III (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES III, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 3,275 | $51.23 | $167,778.25 |
DisclosureSEC source: 0000899243-16-029008 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS III, L.L.C. · CIK 0001532461 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT III, L.P. · CIK 0001532462 · 10% owner WAUD CAPITAL PARTNERS III, L.P. · CIK 0001487016 · 10% owner WAUD CAPITAL PARTNERS QP III, L.P. · CIK 0001487019 · 10% owner WCP FIF III (ACADIA), L.P. · CIK 0001532465 · 10% owner WAUD CAPITAL AFFILIATES III, L.L.C. · CIK 0001532468 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,298,708 F4 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 82 shares by WCP III, (ii) 1,800 shares by Waud QP III, (iii) 1,019 shares by WCP FIF III and (iv) 374 shares by Waud Affiliates III. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners III, L.L.C. ("Waud III LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management III, L.P. ("WCPM III"). Waud III LLC is the general partner of WCPM III. WCPM III is the general partner of WCP III, Waud QP III and WCP FIF III and the manager of Waud Affiliates III. As a result, each of Mr. Waud, Waud III LLC and WCPM III may be deemed to share beneficial ownership of the reported shares. F6 · ownership.nature: The reported shares are owned of record as follows: (i) 194,606 shares by WCP III, (ii) 1,287,433 shares by Waud QP III, (iii) 596,913 shares by WCP FIF III and (iv) 219,756 shares by Waud Affiliates III. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 21:04 UTC |
WAUD CAPITAL PARTNERS II, L.L.C.10% owner
WAUD CAPITAL PARTNERS II, L.P.10% owner
WAUD CAPITAL PARTNERS QP II, L.P.10% owner
WCP FIF II (ACADIA), L.P.10% owner
WAUD CAPITAL AFFILIATES II, L.L.C.10% owner
|
SaleCommon Stock, par value $0.01 per share | 5,933 | $51.23 | $303,947.59 |
DisclosureSEC source: 0000899243-16-029007 · doc4.xml · nonDerivative · entry 2 WAUD CAPITAL PARTNERS II, L.L.C. · CIK 0001532445 · 10% owner WAUD CAPITAL PARTNERS MANAGEMENT II, L.P. · CIK 0001532459 · 10% owner WAUD CAPITAL PARTNERS II, L.P. · CIK 0001299241 · 10% owner WAUD CAPITAL PARTNERS QP II, L.P. · CIK 0001299294 · 10% owner WCP FIF II (ACADIA), L.P. · CIK 0001532463 · 10% owner WAUD CAPITAL AFFILIATES II, L.L.C. · CIK 0001532464 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,701,281 F4 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (4) to this Form 4. F3 · ownership.nature: Reeve B. Waud is a member of the board of directors of Acadia Healthcare Company, Inc. Mr. Waud is also the manager of Waud Capital Partners II, L.L.C. ("Waud II LLC") and a member of the Limited Partner Committee of Waud Capital Partners Management II, L.P. ("WCPM II"). Waud II LLC is the general partner of WCPM II. WCPM II is the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II. As a result, each of Mr. Waud, Waud II LLC and WCPM II may be deemed to share beneficial ownership of the reported shares. F6 · ownership.nature: The reported shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by Waud QP II, (iii) 418,098 shares by WCP FIF II and (iv) 428,204 shares by Waud Affiliates II. F7 · ownership.nature: Each of the reporting persons expressly disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest therein. Read SEC document |
| September 12, 2016 Filed Sep 15, 2016 01:03 UTC |
WAUD REEVE BDirector · 10% owner
|
SaleCommon stock, par value $0.01 per share | 26,679 | $51.77 | $1,381,171.83 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,708,136 F3 · shares: Represents shares sold in market transactions under Rule 144 as follows: (i) 665 shares by Waud Capital Partners III, L.P. ("WCP III"), (ii) 14,664 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (iii) 8,296 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") and (iv) 3,054 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F8 · ownership.nature: Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2016 Filed Sep 15, 2016 01:03 UTC |
WAUD REEVE BDirector · 10% owner
|
SaleCommon stock, par value $0.01 per share | 48,321 | $51.77 | $2,501,578.17 |
DisclosureSEC source: 0000899243-16-029006 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,734,815 F1 · shares: Represents shares sold in multiple transactions under Rule 144 as follows: (i) 9,095 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 27,464 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 5,811 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") and (iv) 5,951 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4. F7 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. F10 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F11 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.